Found 5 matching trials
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
PHASE3The purpose of this study is to verify the safety and the efficacy of TBI-1...
Location
Osaka International Cancer Institute
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
PHASE1The target populations for this phase I study with TBI-1301 are patients wi...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma
PHASE1The purpose of this study is to evaluate the safety and the efficacy of TBI...
Location
Sapporo Medical University Hospital
Investigator Initiated Phase 1 Study of TBI-1301
PHASE1Following pre-treatment with cyclophosphamide and/or fludarabine, NY-ESO-1-...
Location
Mie University Hospital
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
PHASE1This phase Ib trial tests the safety, side effects and best dose of anti-HL...
Location
USC / Norris Comprehensive Cancer Center